Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Shareholder meetings

General Meeting - 25 October 2023

Next Science held a General Meeting on Wednesday, 25 October 2023 at 9:00am (Sydney time).

Click here to listen to the webcast of the General MeetingOpens in new window

Notice of MeetingOpens in new window

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474